NFKB1 and sarcopenia: In addition, as stated in the preface, hypertension is currently recognized as an inflammation-related disease, and multiple inflammatory markers have been shown to be abnormally elevated in hypertensive patients (3–5), Activation of these inflammatory markers promotes sarcopenia through NF-κB and NLRP3 (6, 7).